BioTech

Scottish BioTech Bead BioPharma emerges from stealth mode with novel cancer...

Bead BioPharma, a Scottish life sciences company backed by Archangels, has announced its emergence from stealth mode following the submission of its first patent, a milestone that marks the company’s formal entry into o...

Speech could be a key clinical marker in neurodegenerative disease drug...

Speech is rapidly emerging as an important, non-invasive, digital clinical marker in neurodegenerative disease research, according to leading BioTech, SynaptixBio. The company has facilitated a study run by ...

Regulation is pushing European MedTech to streamline clinical trial...

European MedTech companies are still adjusting to the EU Medical Devices Regulation and the In Vitro Diagnostic Medical Devices Regulation. Now, with the EU AI Act and the European Health Data Space coming into view,...

Creating effective life sciences facilities and innovative clinical...

The life sciences sector in the UK is growing and with this growth comes demand for modern, innovative buildings. Derek Lloyd, Director Development Management UK, at Prologis UK, discusses technology used in modern,...

Patient-centricity in rare disease: Accelerating the path to treatment

Rare Disease Day took place on Saturday. They day is to raise awareness and generate change for the 300 million people worldwide living with a rare disease, their families and carers. Chris Moore, President, Europe at...

Agent-ready data starts with master data management

Master Data Management (MDM) forms the backbone of ‘agent-ready’ data – enabling autonomous AI systems to clean, connect and act on information across commercial, regulatory and R&D workflows. Sowjanya Bukkapatnam Tirum...

Browse our latest issue

Intelligent Health.tech

View Magazine Archive